Skip to main content
. 2021 Mar 22;14(3):515–520. doi: 10.4103/aer.AER_110_20

Table 6.

Comparison of modified objective pain score between group ropivacaine, group ropivacaine+dexamethasone, and group ropivacaine+tramadol (n=30)

Group R Group D Group T P
1 h 2 (2-2) 1 (1-1) 1 (1-1) 0.326
2 h 2 (2-2) 1 (1-1) 1 (1-1) 0.562
3 h 1 (1-1) 1 (1-1) 1 (1-1) 0.682
6 h 4 (3-4) 2 (2-2) 2 (2-2) <0.001*
12 h 4 (4-4) 2 (2-2) 3 (3-3) <0.001*

Data expressed as median and interquartile range. Analyzed by Kruskal-Wallis test. *Statistically significant. Group R=Ropivacaine; Group T=Ropivacaine+tramadol; Group D=Ropivacine+dexamethasone